AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Rituximab in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MabThera 100 mg Concentrate for Solution for Infusion Concentrate for solution for infusion | A6-0266 | — | active | — |
| Mabthera 500 mg Concentrate for Solution for Infusion Concentrate for solution for infusion | A6-0104 | — | active | — |
Rituximab — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Rituximab, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Rituximab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.